{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:53:23Z","timestamp":1790337203133,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Basophil testing is the most effective single approach for diagnosing type-IIb autoimmune chronic spontaneous urticaria (TIIbaiCSU). A positive basophil test has been linked to long disease duration, higher disease activity, a poor response to antihistamines and omalizumab, and a better response to cyclosporine and fenebrutinib. As of now it is unclear what other features are connected to a positive basophil test in chronic spontaneous urticaria (CSU). We aimed to identify features of basophil test-positive CSU patients. We performed a cross-sectional study of 85 CSU patients. Basophil testing was done with the basophil activation test (BAT) and the basophil histamine release assay (BHRA). Data were analysed using SPSS: Student\u2019s t-test, Chi-square test, Odds Ratio, Spearman\u2019s correlation test. Of 85 CSU patients, 44% and 28% tested positive with the BAT and BHRA, respectively. These patients showed higher disease activity and impact, lower levels of disease control and total serum IgE, as well as higher rates of having a positive autologous serum skin test (ASST), angioedema, nocturnal symptoms, symptoms for &amp;gt;5 days\/week, and thyroid autoantibodies. The ASST, by itself, was not a good predictor of basophil test results, but it predicted a positive basophil test in up to 100% of cases when combined with angioedema, thyroid autoantibodies or low IgE. In conclusion, a positive basophil test is linked to known features of TIIbaiCSU and novel characteristics including nocturnal symptoms. Further studies on basophil test-positive and -negative CSU patients can help to better understand CSU endotypes and to develop better management approaches.<\/jats:p>","DOI":"10.3389\/fimmu.2021.742470","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T09:54:47Z","timestamp":1632822887000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["What Basophil Testing Tells Us About CSU Patients \u2013 Results of the CORSA Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Jo\u00e3o","family":"Marcelino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Stahl","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concei\u00e7\u00e3o","family":"Pereira Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Wyroslak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Scheffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Altrichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Woetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Pereira-Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA\u00b2LEN\/EDF\/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.08.050","article-title":"Autoimmune Chronic Spontaneous Urticaria: What We Know and What We do Not Know","volume":"139","author":"Kolkhir","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.09.010","article-title":"Reply","volume":"141","author":"Kolkhir","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/all.13949","article-title":"Biomarkers and Clinical Characteristics of Autoimmune Chronic Spontaneous Urticaria: Results of the PURIST Study","volume":"74","author":"Schoepke","year":"2019","journal-title":"Allergy"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.01.026","article-title":"Relevance of the Basophil High-Affinity IgE Receptor in Chronic Urticaria: Clinical Experience From a Tertiary Care Institution","volume":"7","author":"Deza","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17131","article-title":"Autologous Serum Skin Test Reactions in Chronic Spontaneous Urticaria Differ From Heterologous Cell Reactions","volume":"35","author":"Baumann","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/all.12056","article-title":"EAACI Taskforce Position Paper: Evidence for Autoimmune Urticaria and Proposal for Defining Diagnostic Criteria","volume":"68","author":"Konstantinou","year":"2013","journal-title":"Allergy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.047","article-title":"Serum Autoreactivity Predicts Time to Response to Omalizumab Therapy in Chronic Spontaneous Urticaria","volume":"139","author":"Gericke","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2045-7022-2-19","article-title":"A Positive Serum Basophil Histamine Release Assay Is a Marker for Ciclosporin-Responsiveness in Patients With Chronic Spontaneous Urticaria","volume":"2","author":"Iqbal","year":"2012","journal-title":"Clin Transl Allergy"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2015.11.025","article-title":"Lack of Basophil CD203c-Upregulating Activity as an Immunological Marker to Predict Response to Treatment With Omalizumab in Patients With Symptomatic Chronic Urticaria","volume":"4","author":"Palacios","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.5415\/apallergy.2020.10.e12","article-title":"Relationship Between Changes in the 7-Day Urticaria Activity Score After Treatment With Omalizumab and the Responsiveness of Basophils to Fc\u03f5ri Stimulation in Patients With Chronic Spontaneous Urticaria","volume":"10","author":"Endo","year":"2020","journal-title":"Asia Pac Allergy"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/all.14037","article-title":"Prevalence of Chronic Urticaria in Children and Adults Across the Globe: Systematic Review With Meta-Analysis","volume":"75","author":"Fricke","year":"2020","journal-title":"Allergy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jdv.13695","article-title":"Questions and Answers in Chronic Urticaria: Where do We Stand and Where do We Go","author":"Maurer","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized Double-Blind Study of Cyclosporin in Chronic \u2019Idiopathic\u2019 Urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"Br J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2009.02132.x","article-title":"EAACI\/GA(2)LEN Task Force Consensus Report: The Autologous Serum Skin Test in Urticaria","volume":"64","author":"Konstantinou","year":"2009","journal-title":"Allergy"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/all.12901","article-title":"Definition, Aims, and Implementation of GA\u00b2LEN Urticaria Centers of Reference and Excellence","volume":"71","author":"Maurer","year":"2016","journal-title":"Allergy"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2011.09.008","article-title":"Evaluating the\u00a0Minimally Important Difference of the Urticaria Activity Score and Other Measures of Disease Activity in Patients With Chronic Idiopathic Urticaria","volume":"108","author":"Mathias","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13668","article-title":"Patient-Reported Outcomes (PROs) in Chronic Urticaria","volume":"56","author":"Moestrup","year":"2017","journal-title":"Int J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1365-2133.2008.08832.x","article-title":"The Dermatology Life Quality Index 1994-2007: A Comprehensive Review of Validation Data and Clinical Results","volume":"159","author":"Basra","year":"2008","journal-title":"Br J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1076","article-title":"Development and Validation of the Urticaria Control Test: A Patient-Reported Outcome Instrument for Assessing Urticaria Control","volume":"133","author":"Weller","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15640","article-title":"Immunological Effects and Potential Mechanisms of Action of Autologous Serum Therapy in Chronic Spontaneous Urticaria","volume":"33","author":"Yu","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.11.040","article-title":"Frequency and Clinical Implications of Skin Autoreactivity to Serum Versus Plasma in Patients With Chronic Urticaria","volume":"123","author":"Metz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.05.004","article-title":"Basophil Histamine Release in Patients With Chronic Spontaneous Urticaria: Optimize or Minimize","volume":"144","author":"Kaplan","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.125","article-title":"Basophil Activation Test Identifies the Patients With Chronic Spontaneous Urticaria Suffering the Most Active Disease","volume":"4","author":"Curto-Barredo","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000451084","article-title":"Positive CD63 Basophil Activation Tests Are Common in Children With Chronic Spontaneous Urticaria and Linked to High Disease Activity","volume":"171","author":"Netchiporouk","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2019.3680","article-title":"The CD63 Basophil Activation Test as a Diagnostic Tool for Assessing Autoimmunity in Patients With Chronic Spontaneous Urticaria","volume":"29","author":"Hossein Zadeh Attar","year":"2019","journal-title":"Eur J Dermatol"},{"key":"B27","volume-title":"Diagn\u00f3stico De Urtic\u00e1ria Cr\u00f3nica Autoimune: Estudo De Activa\u00e7\u00e3o Dos Bas\u00f3filos Por Citometria De Fluxo","author":"Costa","year":"2008"},{"key":"B28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2500\/aap.2009.30.3185","article-title":"Comparison of the In Vivo Autologous Skin Test With In Vitro Diagnostic Tests for Diagnosis of Chronic Autoimmune Urticaria","volume":"30","author":"Altrich","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.02.016","article-title":"Chronic Urticaria Sera Increase Basophil CD203c Expression","volume":"117","author":"Yasnowsky","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2133.2006.07205.x","article-title":"Significant Correlation Between the CD63 Assay and the Histamine Release Assay in Chronic Urticaria","volume":"155","author":"Szegedi","year":"2006","journal-title":"Br J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2007.02450.x","article-title":"Serum Interleukin-18 in Patients With Chronic Ordinary Urticaria: Association With Disease Activity","volume":"32","author":"Tedeschi","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.07.021","article-title":"Individual IL-3 Priming is Crucial for Consistent In Vitro Activation of Donor Basophils in Patients With Chronic Urticaria","volume":"128","author":"Gentinetta","year":"2011","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.742470\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T09:54:50Z","timestamp":1632822890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.742470\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2021.742470"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.742470","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"article-number":"742470"}}